RL vs SKYE · P/E 24, rev $8.11B vs $25.0M cap
Ralph Lauren Corp Class A (RL) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
SKYE does not have a complete income-statement cache yet.
RL currently screens at market cap $16.95B and trailing P/E 24.1. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the RL and SKYE stock pages for the full models.
Not investment advice.